| AR (n = 77) . | AS (n = 79) . | CD (n = 136) . | P-value . | |
|---|---|---|---|---|
| Surgery intervals | ||||
| 1995–2005 | 16 (21) | 19 (24) | 34 (25) | 0.982 |
| 2006–2016 | 22 (29) | 20 (25) | 33 (24) | 0.521 |
| 2017–2023 | 39 (50) | 40 (51) | 69 (51) | 0.181 |
| Autograft support, n (%) | ||||
| Annuloplasty | 46 (60) | 46 (58) | 88 (65) | 0.405 |
| Aortic wall inclusion | 56 (73) | 61 (77) | 102 (75) | 0.930 |
| Right ventricular conduit, n (%) | ||||
| Bovine jugular vein | 16 (21) | 4 (5) | 12 (8) | 0.110 |
| Pulmonary homograft | 52 (68) | 56 (71) | 100 (74) | 0.134 |
| Stentless biological prosthesis | 9 (11) | 19 (24) | 24 (18) | 0.272 |
| Concomitant procedure, n (%) | 9 (13) | 7 (9) | 11 (9) | 0.317 |
| Ascending aortic replacement | 14 (18) | 25 (32) | 39 (29) | 0.163 |
| Myocardial ischaemia (min), mean (SD) | 94 (9) | 90 (23) | 89 (18) | 0.191 |
| Perfusion time (min), mean (SD) | 130 (34) | 123 (38) | 122(29) | 0.201 |
| Perioperative complications, n (%) | ||||
| Myocardial infarction | 0 (0) | 0 (0) | 0 (0) | – |
| Stroke | 0 (0) | 0 (0) | 1 (1) | – |
| Permanent pacemaker implant | 4 (5) | 0 (0) | 0 (0) | – |
| Ventricular dysfunction requiring assist devices | 0 (0) | 0 (0) | 2 (1) | – |
| Reopening for bleeding | 0 (0) | 0 (0) | 0 (0) | – |
| AR (n = 77) . | AS (n = 79) . | CD (n = 136) . | P-value . | |
|---|---|---|---|---|
| Surgery intervals | ||||
| 1995–2005 | 16 (21) | 19 (24) | 34 (25) | 0.982 |
| 2006–2016 | 22 (29) | 20 (25) | 33 (24) | 0.521 |
| 2017–2023 | 39 (50) | 40 (51) | 69 (51) | 0.181 |
| Autograft support, n (%) | ||||
| Annuloplasty | 46 (60) | 46 (58) | 88 (65) | 0.405 |
| Aortic wall inclusion | 56 (73) | 61 (77) | 102 (75) | 0.930 |
| Right ventricular conduit, n (%) | ||||
| Bovine jugular vein | 16 (21) | 4 (5) | 12 (8) | 0.110 |
| Pulmonary homograft | 52 (68) | 56 (71) | 100 (74) | 0.134 |
| Stentless biological prosthesis | 9 (11) | 19 (24) | 24 (18) | 0.272 |
| Concomitant procedure, n (%) | 9 (13) | 7 (9) | 11 (9) | 0.317 |
| Ascending aortic replacement | 14 (18) | 25 (32) | 39 (29) | 0.163 |
| Myocardial ischaemia (min), mean (SD) | 94 (9) | 90 (23) | 89 (18) | 0.191 |
| Perfusion time (min), mean (SD) | 130 (34) | 123 (38) | 122(29) | 0.201 |
| Perioperative complications, n (%) | ||||
| Myocardial infarction | 0 (0) | 0 (0) | 0 (0) | – |
| Stroke | 0 (0) | 0 (0) | 1 (1) | – |
| Permanent pacemaker implant | 4 (5) | 0 (0) | 0 (0) | – |
| Ventricular dysfunction requiring assist devices | 0 (0) | 0 (0) | 2 (1) | – |
| Reopening for bleeding | 0 (0) | 0 (0) | 0 (0) | – |
AR: aortic regurgitation; AS: aortic stenosis; CD: combined disease; SD: standard deviation.
| AR (n = 77) . | AS (n = 79) . | CD (n = 136) . | P-value . | |
|---|---|---|---|---|
| Surgery intervals | ||||
| 1995–2005 | 16 (21) | 19 (24) | 34 (25) | 0.982 |
| 2006–2016 | 22 (29) | 20 (25) | 33 (24) | 0.521 |
| 2017–2023 | 39 (50) | 40 (51) | 69 (51) | 0.181 |
| Autograft support, n (%) | ||||
| Annuloplasty | 46 (60) | 46 (58) | 88 (65) | 0.405 |
| Aortic wall inclusion | 56 (73) | 61 (77) | 102 (75) | 0.930 |
| Right ventricular conduit, n (%) | ||||
| Bovine jugular vein | 16 (21) | 4 (5) | 12 (8) | 0.110 |
| Pulmonary homograft | 52 (68) | 56 (71) | 100 (74) | 0.134 |
| Stentless biological prosthesis | 9 (11) | 19 (24) | 24 (18) | 0.272 |
| Concomitant procedure, n (%) | 9 (13) | 7 (9) | 11 (9) | 0.317 |
| Ascending aortic replacement | 14 (18) | 25 (32) | 39 (29) | 0.163 |
| Myocardial ischaemia (min), mean (SD) | 94 (9) | 90 (23) | 89 (18) | 0.191 |
| Perfusion time (min), mean (SD) | 130 (34) | 123 (38) | 122(29) | 0.201 |
| Perioperative complications, n (%) | ||||
| Myocardial infarction | 0 (0) | 0 (0) | 0 (0) | – |
| Stroke | 0 (0) | 0 (0) | 1 (1) | – |
| Permanent pacemaker implant | 4 (5) | 0 (0) | 0 (0) | – |
| Ventricular dysfunction requiring assist devices | 0 (0) | 0 (0) | 2 (1) | – |
| Reopening for bleeding | 0 (0) | 0 (0) | 0 (0) | – |
| AR (n = 77) . | AS (n = 79) . | CD (n = 136) . | P-value . | |
|---|---|---|---|---|
| Surgery intervals | ||||
| 1995–2005 | 16 (21) | 19 (24) | 34 (25) | 0.982 |
| 2006–2016 | 22 (29) | 20 (25) | 33 (24) | 0.521 |
| 2017–2023 | 39 (50) | 40 (51) | 69 (51) | 0.181 |
| Autograft support, n (%) | ||||
| Annuloplasty | 46 (60) | 46 (58) | 88 (65) | 0.405 |
| Aortic wall inclusion | 56 (73) | 61 (77) | 102 (75) | 0.930 |
| Right ventricular conduit, n (%) | ||||
| Bovine jugular vein | 16 (21) | 4 (5) | 12 (8) | 0.110 |
| Pulmonary homograft | 52 (68) | 56 (71) | 100 (74) | 0.134 |
| Stentless biological prosthesis | 9 (11) | 19 (24) | 24 (18) | 0.272 |
| Concomitant procedure, n (%) | 9 (13) | 7 (9) | 11 (9) | 0.317 |
| Ascending aortic replacement | 14 (18) | 25 (32) | 39 (29) | 0.163 |
| Myocardial ischaemia (min), mean (SD) | 94 (9) | 90 (23) | 89 (18) | 0.191 |
| Perfusion time (min), mean (SD) | 130 (34) | 123 (38) | 122(29) | 0.201 |
| Perioperative complications, n (%) | ||||
| Myocardial infarction | 0 (0) | 0 (0) | 0 (0) | – |
| Stroke | 0 (0) | 0 (0) | 1 (1) | – |
| Permanent pacemaker implant | 4 (5) | 0 (0) | 0 (0) | – |
| Ventricular dysfunction requiring assist devices | 0 (0) | 0 (0) | 2 (1) | – |
| Reopening for bleeding | 0 (0) | 0 (0) | 0 (0) | – |
AR: aortic regurgitation; AS: aortic stenosis; CD: combined disease; SD: standard deviation.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
